Radiation therapy‐associated toxicity: Etiology, management, and prevention

K Wang, JE Tepper - CA: a cancer journal for clinicians, 2021 - Wiley Online Library
Radiation therapy (RT) is a curative treatment for many malignancies and provides effective
palliation in patients with tumor‐related symptoms. However, the biophysical effects of RT …

Advances in PET imaging of cancer

J Schwenck, D Sonanini, JM Cotton… - Nature Reviews …, 2023 - nature.com
Molecular imaging has experienced enormous advancements in the areas of imaging
technology, imaging probe and contrast development, and data quality, as well as machine …

Radiotheranostics in oncology: making precision medicine possible

EO Aboagye, TD Barwick… - CA: A Cancer Journal for …, 2023 - Wiley Online Library
A quintessential setting for precision medicine, theranostics refers to a rapidly evolving field
of medicine in which disease is diagnosed followed by treatment of disease‐positive …

Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants

D Taïeb, GB Wanna, M Ahmad… - The Lancet Diabetes & …, 2023 - thelancet.com
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …

[HTML][HTML] Radiolabeled somatostatin analogs—a continuously evolving class of radiopharmaceuticals

M Fani, R Mansi, GP Nicolas, D Wild - Cancers, 2022 - mdpi.com
Simple Summary Somatostatin receptors (SSTs) are of particular interest in oncology
because these proteins are overexpressed on the cell membranes of different human …

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma

H Sorbye, E Grande, M Pavel, M Tesselaar, N Fazio… - 2023 - bora.uib.no
This ENETS guidance paper, developed by a multidisciplinary working group, provides up-
to-date and practical advice on the diagnosis and management of digestive neuroendocrine …

Peptide receptor radionuclide therapy

J Hofland, T Brabander, FA Verburg… - The Journal of …, 2022 - academic.oup.com
The concept of using a targeting molecule labeled with a diagnostic radionuclide for using
positron emission tomography or single photon emission computed tomography imaging …

[HTML][HTML] Peptide receptor radionuclide therapy (PRRT): innovations and improvements

E Merola, CM Grana - Cancers, 2023 - mdpi.com
Simple Summary This article discusses the use of peptide receptor radionuclide therapy
(PRRT) as a key treatment method for advanced, unresectable neuroendocrine tumors. It …

[HTML][HTML] PSMA theranostics: current landscape and future outlook

H Zhang, S Koumna, F Pouliot, JM Beauregard… - Cancers, 2021 - mdpi.com
Simple Summary The prognosis for metastatic prostate cancer patients remains poor.
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer and is a …

Gastric neuroendocrine neoplasms

G Lamberti, F Panzuto, M Pavel, D O'Toole… - Nature Reviews …, 2024 - nature.com
Gastric neuroendocrine neoplasms (gNENs) display peculiar site-specific features among
all NENs. Their incidence and prevalence have been rising in the past few decades. gNENs …